New Developments in Transcriptomic Analysis of Synovial Tissue.

fibroblast microarray pathotype sequencing single-cell stratification synovium transcriptomics

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2020
Historique:
received: 26 11 2019
accepted: 14 01 2020
entrez: 22 2 2020
pubmed: 23 2 2020
medline: 23 2 2020
Statut: epublish

Résumé

Transcriptomic technologies are constantly changing and improving, resulting in an ever increasing understanding of gene expression in health and disease. These technologies have been used to investigate the pathological changes occurring in the joints of rheumatoid arthritis patients, leading to discoveries of disease mechanisms, and novel potential therapeutic targets. Microarrays were initially used on both whole tissue and cell subsets to investigate research questions, with bulk RNA sequencing allowing for further elaboration of these findings. A key example is the classification of pathotypes in rheumatoid arthritis using RNA sequencing that had previously been discovered using microarray and histology. Single-cell sequencing has now delivered a step change in understanding of the diversity and function of subpopulations of cells, in particular synovial fibroblasts. Future technologies, such as high resolution spatial transcriptomics, will enable step changes integrating single cell transcriptomic and geographic data to provide an integrated understanding of synovial pathology.

Identifiants

pubmed: 32083090
doi: 10.3389/fmed.2020.00021
pmc: PMC7005068
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

21

Subventions

Organisme : Medical Research Council
ID : MC_PC_16037
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M007669/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P021220/1
Pays : United Kingdom

Informations de copyright

Copyright © 2020 Carr, Turner, Major, Scheel-Toellner and Filer.

Références

Nat Commun. 2018 Feb 23;9(1):789
pubmed: 29476097
Nat Immunol. 2019 Jul;20(7):928-942
pubmed: 31061532
J Clin Invest. 1989 Apr;83(4):1267-76
pubmed: 2784799
Arthritis Res Ther. 2006;8(6):R171
pubmed: 17105646
Scand J Rheumatol. 2012 May;41(3):170-9
pubmed: 22401175
Ann Rheum Dis. 2011 Oct;70(10):1857-65
pubmed: 21798884
Int Immunol. 2000 Feb;12(2):187-93
pubmed: 10653854
PLoS Genet. 2006 Jul;2(7):e119
pubmed: 16895450
Arthritis Rheum. 2005 Feb;52(2):430-41
pubmed: 15692990
Immunity. 2017 Feb 21;46(2):220-232
pubmed: 28228280
Nat Biotechnol. 2017 Oct;35(10):936-939
pubmed: 28854175
Br J Rheumatol. 1995 Apr;34(4):321-5
pubmed: 7788145
Arthritis Res Ther. 2018 Jul 11;20(1):139
pubmed: 29996944
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12877-82
pubmed: 12297622
Dev Dyn. 2012 Nov;241(11):1816-26
pubmed: 22972626
Arthritis Rheum. 2006 Jul;54(7):2096-108
pubmed: 16802344
Nat Rev Rheumatol. 2013 Jan;9(1):24-33
pubmed: 23147896
Arthritis Rheumatol. 2018 May;70(5):690-701
pubmed: 29468833
Nat Methods. 2017 Sep;14(9):865-868
pubmed: 28759029
Ann Rheum Dis. 2019 Jun;78(6):761-772
pubmed: 30878974
Arthritis Res Ther. 2013 Feb 20;15(1):R31
pubmed: 23421940
Ann Rheum Dis. 1975 Jun;34(3):219-24
pubmed: 1155980
PLoS One. 2012;7(7):e40620
pubmed: 22792388
J Clin Invest. 2001 Feb;107(3):305-15
pubmed: 11160154
Nature. 2017 Feb 1;542(7639):110-114
pubmed: 28150777
Arthritis Res Ther. 2016 Nov 18;18(1):270
pubmed: 27863512
Arthritis Res Ther. 2016 Apr 04;18:83
pubmed: 27044395
Lancet. 2016 Oct 22;388(10055):2023-2038
pubmed: 27156434
Arthritis Rheum. 2013 Apr;65(4):928-38
pubmed: 23335080
Cell Rep. 2019 Aug 27;28(9):2455-2470.e5
pubmed: 31461658
Arthritis Rheum. 2003 Apr;48(4):1002-14
pubmed: 12687542
Nat Genet. 1999 Jan;21(1 Suppl):15-9
pubmed: 9915495
Arthritis Res Ther. 2014;16(2):R90
pubmed: 25167216
Ann Rheum Dis. 2017 Jun;76(6):960-977
pubmed: 28264816
Arthritis Res Ther. 2015 Jan 20;17:12
pubmed: 25600705
Matrix Biol. 2014 Oct;39:17-24
pubmed: 25172828
Nat Genet. 1999 Jan;21(1 Suppl):5-9
pubmed: 9915493
Best Pract Res Clin Rheumatol. 2008 Apr;22(2):221-38
pubmed: 18455681
PLoS One. 2010 Jun 25;5(6):e11310
pubmed: 20593016
PLoS One. 2017 Aug 9;12(8):e0182751
pubmed: 28793332
Ann Rheum Dis. 2017 Dec;76(12):2105-2112
pubmed: 28847766
Open Rheumatol J. 2011;5:100-6
pubmed: 22279508
Wiley Interdiscip Rev RNA. 2017 Jan;8(1):
pubmed: 27198714
Arthritis Res Ther. 2006;8(2):R47
pubmed: 16507157
Arthritis Rheum. 1995 May;38(5):669-77
pubmed: 7748222
Nature. 2019 Jun;570(7760):246-251
pubmed: 31142839
Am J Pathol. 1997 Mar;150(3):1125-38
pubmed: 9060847
Genes Immun. 2003 Apr;4(3):187-96
pubmed: 12700593

Auteurs

Hayley L Carr (HL)

Institute for Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.

Jason D Turner (JD)

Institute for Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.

Triin Major (T)

Institute for Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.

Dagmar Scheel-Toellner (D)

Institute for Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.

Andrew Filer (A)

Institute for Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.
NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.

Classifications MeSH